A Phase I Trial of Subcutaneous QLS7305 in Healthy Adults

Clinical trial NCT07313150 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07313150
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers - Male and Female

Start date: 2026-01-01
Primary completion: 2027-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.